Leveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology.

Many psychiatric drugs modulate the nervous system through multitarget mechanisms. However, systematic identification of multitarget compounds has been difficult using traditional in vitro screening assays. New approaches to phenotypic profiling in zebrafish can help researchers identify novel compounds with complex polypharmacology. For example, large-scale behavior-based chemical screens can rapidly identify large numbers of structurally diverse and phenotype-related compounds. Once these compounds have been identified, a systems-level analysis of their structures may help to identify statistically enriched target pathways. Together, systematic behavioral profiling and multitarget predictions may help researchers identify new behavior-modifying pathways and CNS therapeutics.

[1]  R. Iyengar,et al.  Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. , 2012, Annual review of pharmacology and toxicology.

[2]  Urban Liebel,et al.  Behavioral barcoding in the cloud: embracing data-intensive digital phenotyping in neuropharmacology. , 2012, Trends in biotechnology.

[3]  R. Gerlai,et al.  MK-801 increases locomotor activity in a context-dependent manner in zebrafish , 2016, Behavioural Brain Research.

[4]  M. Markowicz,et al.  Adaptation of High-Throughput Screening in Drug Discovery—Toxicological Screening Tests , 2011, International journal of molecular sciences.

[5]  Evan J. Kyzar,et al.  Zebrafish models to study drug abuse-related phenotypes , 2011, Reviews in the neurosciences.

[6]  G. Griebel,et al.  50 years of hurdles and hope in anxiolytic drug discovery , 2013, Nature Reviews Drug Discovery.

[7]  Diogo R. Lara,et al.  Effects of anxiolytics in zebrafish: Similarities and differences between benzodiazepines, buspirone and ethanol , 2011, Pharmacology Biochemistry and Behavior.

[8]  M. Sundvik,et al.  The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases , 2010, Neurobiology of Disease.

[9]  Ethan K. Scott,et al.  Optogenetic dissection of a behavioral module in the vertebrate spinal cord , 2009, Nature.

[10]  Masahiko Sugimoto,et al.  A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development , 2010, BMC Developmental Biology.

[11]  A. Pradhan,et al.  Zebrafish sexual behavior: role of sex steroid hormones and prostaglandins , 2015, Behavioral and Brain Functions.

[12]  Michael R Hamblin,et al.  Photochemical activation of TRPA1 channels in neurons and animals , 2013, Nature chemical biology.

[13]  Siddharth Gaikwad,et al.  Unique and potent effects of acute ibogaine on zebrafish: The developing utility of novel aquatic models for hallucinogenic drug research , 2013, Behavioural Brain Research.

[14]  J. Bajorath,et al.  Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.

[15]  L. Wodicka,et al.  Dual kinase-bromodomain inhibitors for rationally designed polypharmacology , 2014, Nature chemical biology.

[16]  Ralf Mikut,et al.  Identification of Nonvisual Photomotor Response Cells in the Vertebrate Hindbrain , 2013, The Journal of Neuroscience.

[17]  Bryan L. Roth,et al.  Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen , 2011, Nature chemical biology.

[18]  D. Prober,et al.  Melatonin Is Required for the Circadian Regulation of Sleep , 2015, Neuron.

[19]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[20]  R. Gerlai,et al.  Serotonin antagonists induce anxiolytic and anxiogenic-like behavior in zebrafish in a receptor-subtype dependent manner , 2014, Pharmacology Biochemistry and Behavior.

[21]  Su Guo,et al.  Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes , 2010, Neurobiology of Disease.

[22]  D. Balciunas,et al.  Extreme Thermal Noxious Stimuli Induce Pain Responses in Zebrafish Larvae , 2014, Journal of cellular physiology.

[23]  J. Hogenesch,et al.  A Genome-wide Screen Id entifies PAPP-AA-Mediated IGFR Signaling as a Novel Regulator of Habituation Learning , 2013 .

[24]  Evan J. Kyzar,et al.  Three-Dimensional Neurophenotyping of Adult Zebrafish Behavior , 2011, PloS one.

[25]  Stephan C F Neuhauss,et al.  Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. , 2013, Zebrafish.

[26]  Ethan K. Scott,et al.  Filtering of Visual Information in the Tectum by an Identified Neural Circuit , 2010, Science.

[27]  Emmanuel Mignot,et al.  Genomic and functional conservation of sedative-hypnotic targets in the zebrafish , 2007, Pharmacogenetics and genomics.

[28]  Michael Granato,et al.  Sensorimotor Gating in Larval Zebrafish , 2007, The Journal of Neuroscience.

[29]  Randall T Peterson,et al.  15 years of zebrafish chemical screening. , 2015, Current opinion in chemical biology.

[30]  Siddharth Gaikwad,et al.  Characterization of behavioral and endocrine effects of LSD on zebrafish , 2010, Behavioural Brain Research.

[31]  Maria F. Sassano,et al.  In Silico Molecular Comparisons of C. elegans and Mammalian Pharmacology Identify Distinct Targets That Regulate Feeding , 2013, PLoS biology.

[32]  D. Prober,et al.  Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish , 2015, eLife.

[33]  Evan J. Kyzar,et al.  Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[35]  S. Ryu,et al.  The behavior of larval zebrafish reveals stressor-mediated anorexia during early vertebrate development , 2014, Front. Behav. Neurosci..

[36]  B. Roth,et al.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.

[37]  S. Higashijima,et al.  The habenula is crucial for experience-dependent modification of fear responses in zebrafish , 2010, Nature Neuroscience.

[38]  A. Stewart,et al.  Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. , 2013, ACS chemical neuroscience.

[39]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[40]  N. Craddock,et al.  Genetics of bipolar disorder , 1999, Journal of medical genetics.

[41]  Silvio Morato,et al.  Scototaxis as anxiety-like behavior in fish , 2010, Nature Protocols.

[42]  Randall T Peterson,et al.  Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. , 2008, Briefings in functional genomics & proteomics.

[43]  Kyu-Won Kim,et al.  Functional and developmental analysis of the blood–brain barrier in zebrafish , 2008, Brain Research Bulletin.

[44]  J. Dowling,et al.  Small molecule developmental screens reveal the logic and timing of vertebrate development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Haggarty,et al.  Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation , 2010, Science.

[46]  Lani F. Wu,et al.  Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities , 2010, Molecular systems biology.

[47]  Evan J. Kyzar,et al.  Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish , 2013, Brain Research.

[48]  Antonio Carrieri,et al.  Recent trends and future prospects in computational GPCR drug discovery: from virtual screening to polypharmacology. , 2013, Current topics in medicinal chemistry.

[49]  Maria F. Sassano,et al.  Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides. , 2015, Chemistry & biology.

[50]  Michael C Neale,et al.  Evidence for multiple genetic factors underlying DSM-IV criteria for major depression. , 2013, JAMA psychiatry.

[51]  Christian Laggner,et al.  Rapid behavior—based identification of neuroactive small molecules in the zebrafish , 2009, Nature chemical biology.

[52]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[53]  Florian Engert,et al.  A Convergent and Essential Interneuron Pathway for Mauthner-Cell-Mediated Escapes , 2015, Current Biology.

[54]  B. Roth,et al.  The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .

[55]  B. Eliceiri,et al.  Zebrafish model of the blood-brain barrier: morphological and permeability studies. , 2011, Methods in molecular biology.

[56]  Alexander F Schier,et al.  Behavioral screening for neuroactive drugs in zebrafish , 2012, Developmental neurobiology.

[57]  A. Giordano,et al.  The zebrafish as a model for nociception studies , 2013, Journal of cellular physiology.

[58]  Steven G Potkin,et al.  Atypical antipsychotic drug actions: unitary or multiple mechanisms for ‘atypicality’? , 2003, Clinical Neuroscience Research.

[59]  Differential effects of acute administration of SCH-23390, a D1 receptor antagonist, and of ethanol on swimming activity, anxiety-related responses, and neurochemistry of zebrafish , 2015, Psychopharmacology.

[60]  Scott C. Baraban,et al.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet Syndrome treatment , 2013, Nature Communications.

[61]  Maria F. Sassano,et al.  Automated design of ligands to polypharmacological profiles , 2012, Nature.

[62]  John P. Overington,et al.  Probing the links between in vitro potency, ADMET and physicochemical parameters , 2011, Nature Reviews Drug Discovery.

[63]  Monica Gomes Lima,et al.  Fingerprinting of Psychoactive Drugs in Zebrafish Anxiety-Like Behaviors , 2014, PloS one.

[64]  H. Burgess,et al.  The Dorsal Raphe Modulates Sensory Responsiveness during Arousal in Zebrafish , 2012, The Journal of Neuroscience.

[65]  G. Peng,et al.  Effects of lorazepam and WAY-200070 in larval zebrafish light/dark choice test , 2015, Neuropharmacology.

[66]  J. L. Snekser,et al.  Fin-mutant female zebrafish (Danio rerio) exhibit differences in association preferences for male fin length , 2009, Behavioural Processes.

[67]  Randall T Peterson,et al.  Using the zebrafish photomotor response for psychotropic drug screening. , 2011, Methods in cell biology.

[68]  H. Wolburg,et al.  Establishment of a neuroepithelial barrier by Claudin5a is essential for zebrafish brain ventricular lumen expansion , 2010, Proceedings of the National Academy of Sciences.

[69]  Florian Engert,et al.  A high-throughput assay for quantifying appetite and digestive dynamics. , 2015, American journal of physiology. Regulatory, integrative and comparative physiology.

[70]  D. Raible,et al.  Modeling Nociception in Zebrafish: A Way Forward for Unbiased Analgesic Discovery , 2015, PloS one.

[71]  Xiuyun Liu,et al.  Influences of acute ethanol exposure on locomotor activities of zebrafish larvae under different illumination. , 2015, Alcohol.

[72]  Drew N. Robson,et al.  Brain-wide neuronal dynamics during motor adaptation in zebrafish , 2012, Nature.